Penumbra, Inc.
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need.
Follow us on Twitter @Penumbrainc @PenVascular @PenNeuro
Follow us on LinkedIn
Visit our website at www.penumbrainc.com
The STRIDE Study for Acute Limb Ischemia, 30-Day Results
By
Penumbra, Inc.
FEATURING
Thomas Maldonado
By
Penumbra, Inc.
FEATURING
Thomas Maldonado
For US HCPs: Presented at VAM 2023, the STRIDE Study 30-day results show that the use of Penumbra's Indigo aspiration system in lower-extremity acute limb ischemia is safe and effective with high target limb salvage and low mortality rates. National Principal Investigator, Dr. Tom Maldonado, shares the key results.
Comments 0
Login to view comments.
Click here to Login
